| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/12/2007 | CA2636110A1 Resistance to physiological disorders in lettuce |
| 07/12/2007 | CA2636084A1 Screening method for selecting plants that show a reduced wound-induced surface discolouration and plant and plant parts thus obtained |
| 07/12/2007 | CA2635660A1 Spider silk proteins and methods for producing spider silk proteins |
| 07/12/2007 | CA2635623A1 Anti-cd19 antibodies with reduced immunogenicity |
| 07/12/2007 | CA2635618A1 Interleukin-12p40 variants with improved stability |
| 07/12/2007 | CA2635615A1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130 |
| 07/12/2007 | CA2635560A1 Chicken virus vaccine and diagnostic |
| 07/12/2007 | CA2634334A1 Interfering rnas targeting the morbillivirus nucleoprotein gene |
| 07/12/2007 | CA2633988A1 Increased seed size and seed number through transgenic over expression of revoluta during early embryo development |
| 07/12/2007 | CA2632947A1 Nucleotide sequences and corresponding polypeptides conferring modulated plant growth rate and biomass in plants |
| 07/12/2007 | CA2632918A1 Method for preventing and/or treating articles or media contaminated with bacteria of the legionella genus |
| 07/11/2007 | EP1806412A1 Method of estimating the secondary processing properties of wheat in growth stage |
| 07/11/2007 | EP1806410A2 Fluorescent multiplex HPV PCR assays using multiple fluorophores |
| 07/11/2007 | EP1806407A2 DNA sequences having anti-repressor activity |
| 07/11/2007 | EP1806406A2 Directed evolution method |
| 07/11/2007 | EP1806405A2 Vectors, cells and processes for pyrimidine deoxyribonucleosides production |
| 07/11/2007 | EP1806404A1 Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 07/11/2007 | EP1806403A2 Human cancer antigen NY ESO 1/CAG-3 and gene encoding same |
| 07/11/2007 | EP1806402A2 CTLA4/CD28 ligands and uses therefor |
| 07/11/2007 | EP1806401A1 Dna encoding novel enzyme having d-serine synthase activity, method of producing the enzyme and method of producing d-serine by using the same |
| 07/11/2007 | EP1806399A2 Nucleic acid molecules encoding a branching enzyme comprising bacteria of the genus Neisseria and method for producing alpha-1.6-branched alpha-1, 4-glucanes |
| 07/11/2007 | EP1806398A1 Fad-2 mutants and high oleic plants |
| 07/11/2007 | EP1806364A2 New anti-IGF-IR antibodies and their applications |
| 07/11/2007 | EP1806363A1 METHOD OF DETECTING HEPATITIS B VIRUS s ANTIGEN |
| 07/11/2007 | EP1806362A2 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 07/11/2007 | EP1806360A2 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 07/11/2007 | EP1806357A1 Hypoxia inducible factor-1 and method of use |
| 07/11/2007 | EP1806353A1 Antisense modulation of novel anti-apoptotic BCL-2-related proteins |
| 07/11/2007 | EP1806180A1 Concentration and purification of analytes using electric field |
| 07/11/2007 | EP1806146A1 Agonists or antagonists of cutaneous T cell-attracting chemokine (CTACK) or vasoactive intestinal contractor (VIC) chemokines |
| 07/11/2007 | EP1806145A1 Remedy for inflammatory diseases |
| 07/11/2007 | EP1806144A2 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 07/11/2007 | EP1806143A2 Baff receptor (BCMA), an immunoregulatory agent |
| 07/11/2007 | EP1806142A1 Method for the production of (poly)peptides by using truncated variants of the SV 40 large T antigen with an intact N terminus |
| 07/11/2007 | EP1806139A2 Immune stimulation using chemically modified RNA |
| 07/11/2007 | EP1805326A2 A method of nucleic acid typing for selecting registered donors for cross-matching to transfusion recipients |
| 07/11/2007 | EP1805315A2 Pufa polyketide synthase systems and uses thereof |
| 07/11/2007 | EP1805312A1 Methods and means for producing hyaluronan |
| 07/11/2007 | EP1805311A2 Terpene hydroxylation |
| 07/11/2007 | EP1805310A2 Scarecrow-like stress-related polypeptides and method sof use in plants |
| 07/11/2007 | EP1805309A2 C1q related protein |
| 07/11/2007 | EP1805308A2 Multidomain rna molecules comprising at least one aptamer for delivering double stranded rna to pest organisms |
| 07/11/2007 | EP1805307A1 Protection of biologically active molecules using amphiphiles |
| 07/11/2007 | EP1805306A1 Vehicle to transport a dna-modifying enzyme to a genome |
| 07/11/2007 | EP1805305A1 Vehicle for the transport of a chosen molecule to a cell |
| 07/11/2007 | EP1805304A2 Improved alanine 2,3-aminomutases and related polynucleotides |
| 07/11/2007 | EP1805302A1 Hydrolysis of ester bonds with lipase |
| 07/11/2007 | EP1805296A1 Stable genomic integration of multiple polynucleotide copies |
| 07/11/2007 | EP1805219A1 Angiopoietin-2 specific binding agents |
| 07/11/2007 | EP1805214A2 T-cell stimulatory peptides from the melanoma-associated chondroitin sulfate proteoglycan and their use |
| 07/11/2007 | EP1805200A2 Neurotransmitter sensors and methods of using the same |
| 07/11/2007 | EP1805198A2 Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same |
| 07/11/2007 | EP1804972A2 Multiple cartridge, cartridge array frame, and recovery container |
| 07/11/2007 | EP1804839A2 Improved expression of factor ix in gene therapy vectors |
| 07/11/2007 | EP1804835A2 Multimeric constructs |
| 07/11/2007 | EP1804831A2 Listeria-based and llo-based vaccines |
| 07/11/2007 | EP1804570A2 Reproductive ablation constructs |
| 07/11/2007 | EP1804569A2 Modification of plant lignin content |
| 07/11/2007 | EP1747274A4 Preparation method for the production of active and soluble proteins in prokaryotes and polycistronic vectors therefor |
| 07/11/2007 | EP1730278A4 Method for preparation and purification of recombinant proteins |
| 07/11/2007 | EP1713905A4 Protein with activity of hydrolyzing amylopectin, starch, glycogen and amylose, gene encoding the same, cell expressing the same, and production method thereof |
| 07/11/2007 | EP1679950A4 Tomatoes having reduced polygalacturonase activity caused by non-transgenic mutations in the polygalacturonase gene |
| 07/11/2007 | EP1678308A4 Expression vector for secreting antibody fragment using e. coli signal sequence and method for mass-producing antibody fragment |
| 07/11/2007 | EP1673625A4 Generation of stabilized proteins by combinatorial consensus mutagenesis |
| 07/11/2007 | EP1664301A4 Novel rat calcium channel subunits and related probes, cell lines and methods |
| 07/11/2007 | EP1639029B1 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/11/2007 | EP1565557B1 Mismatch endonucleases and methods of use |
| 07/11/2007 | EP1535065A4 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 07/11/2007 | EP1509619A4 Pyrophosphorolysis activated polymerization (pap) |
| 07/11/2007 | EP1506408A4 Methods for diagnosing htlv-i-mediated diseases |
| 07/11/2007 | EP1496737B1 .ce1, a regulator of cold induced transcriptome and freezing tolerance in plants |
| 07/11/2007 | EP1483402A4 Apparatus and method for amplifying a polynucleotide |
| 07/11/2007 | EP1456645B1 Methods for determining the prognosis for cancer patients using tucan |
| 07/11/2007 | EP1403381B1 Improved method for detecting and identifying microorganism causative of infection |
| 07/11/2007 | EP1395829B1 Cancer associated protein |
| 07/11/2007 | EP1373870B1 Device for referencing fluorescence signals |
| 07/11/2007 | EP1370666B1 Genetic immunisation against cervical carcinoma |
| 07/11/2007 | EP1320579B1 High growth methanotrophic bacterial strain methylomonas 16a |
| 07/11/2007 | EP1242108B1 Optimized minigenes and peptides encoded thereby |
| 07/11/2007 | EP1237925B1 Mutant er-alpha and test systems for transactivation |
| 07/11/2007 | EP1228228B1 Sorghum dwarfing genes and methods of use |
| 07/11/2007 | EP1218504B1 Gl50 molecules and uses therefor |
| 07/11/2007 | EP1214399B1 High level cytokine production with enhanced cell viability |
| 07/11/2007 | EP1209232B1 Regulating plant branching |
| 07/11/2007 | EP1206284B1 Method for delivery of therapeutic agents using a solution of dextrin |
| 07/11/2007 | EP1179184B1 Identifying material from a breast duct |
| 07/11/2007 | EP1154788B1 Inhibitors of separin, method for identifying them and uses |
| 07/11/2007 | EP1146889B1 IDENTIFICATION OF SPECIFIC DIFFERENTIALLY EXPRESSED MYCOBACTERIAL ANTIGENS AND MEDICAL USE OF THE MYCOBACTERIAL PROTEINS Rv0068 AND Rv3407 |
| 07/11/2007 | EP1141418B1 Selecting animals for parentally imprinted traits |
| 07/11/2007 | EP1141283B1 NOVEL METHOD FOrR IDENTIFICATION OF A COMPOUND MODULATING INTERACTION BETWEEN A TNF LIGAND AND ITS RECEPTOR ON B CELLS |
| 07/11/2007 | EP1131466B1 Method for the quantitative detection of nucleic acids |
| 07/11/2007 | EP1129100B1 Selection system for generating efficient packaging cells for lentiviral vectors |
| 07/11/2007 | EP1071767B1 Gene coding for heliomicine and use thereof |
| 07/11/2007 | EP1065270B1 HUMAN p51 GENES AND GENE PRODUCTS THEREOF |
| 07/11/2007 | EP1037917B1 Recombinant nodavirus compositions and methods |
| 07/11/2007 | EP1019430B1 Method for isolating a nucleic acid |
| 07/11/2007 | EP0979246B1 Human monoclonal antibodies to epidermal growth factor receptor |
| 07/11/2007 | EP0975771B1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins |
| 07/11/2007 | EP0904352B1 Cell line |
| 07/11/2007 | EP0857208B1 Chimaeric oligonucleotides and uses thereof in the identification of antisense binding sites |